Babraham Institute | GenomeWeb

Babraham Institute

Babraham Institute researchers used promoter capture Hi-C to determine the interactomes of 31,000 promoters in blood cells.

In a paper published today in Nature Methods, the researchers applied scM&T-seq to profile the transcriptomes and epigenomes of mouse embryonic stem cells.

NEW YORK (GenomeWeb) – A UK research team has come up with a new method for applying bisulfite sequencing-based methylation profiling to individual cells.

DNAStar said this week that researchers at the Babraham Institute will use its Lasergene software for sequence assembly and analysis.
The financial terms of the licensing arrangement were not disclosed.

NEW YORK (GenomeWeb News) – By zooming in on the chromosomes of single cells, researchers led by Peter Fraser from the Babraham Institute in the UK found that chromosome structure varies between cells, as they reported in Nature today.

NEW YORK (GenomeWeb News) – The UK's Biotechnology and Biological Sciences Research Council will invest £19 million ($29.8 million) in the Genome Analysis Center at the Norwich Research Park in the UK as part of a broader, five-year £250 million ($392 million) investment in the biosciences.

The new budget proposal from UK Prime Minister Cameron's government seeks $161.2 million in new R&D facilities and infrastructure spending.

Babraham Bioscience Technologies Ltd. has attracted three new companies to the £4 million ($6.4 million) Maia building, while relocating four other startups there from smaller spaces within its campus.

ProteoMonitor spoke to David Oxley, head of the protein mass-spec lab at the Babraham Institute in Cambridge, UK, about the new mass spectrometers his lab has obtained, what research they'll be used for, and the use of mass spec in proteomics and metabolomics research generally.

The British institute received a grant from the East of England Development Agency that enabled the firm to purchase the system, which will be available to firms in the area looking to define therapeutic and diagnostic targets.

Pages

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.